Page last updated: 2024-08-25

nipradilol and Heart Disease, Ischemic

nipradilol has been researched along with Heart Disease, Ischemic in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anttila, V; del Nido, P; Suematsu, Y; Takamoto, S	1
Akima, T; Ishihara, M; Kurita, A; Mastui, T; Ohsuzu, F; Satomura, K; Takase, B	1
Hikita, H; Kurita, A; Mitani, H; Mizuno, K; Nakamura, H; Nishioka, T; Satomura, K; Takase, B; Uehata, A	1
Gaudette, GR; Horimoto, H; Krukenkamp, IB; Saltman, AE	1
Hikita, H; Kurita, A; Mastui, T; Ohsuzu, F; Satomura, K; Takase, B	1

Trials

1 trial(s) available for nipradilol and Heart Disease, Ischemic

Article	Year
Day-to-day variability of the long-term fractal component of heart rate variability (beta) and the effect of an antianginal agent in patients with silent myocardial ischemia. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2004, Volume: 58 Suppl 1 Topics: Adrenergic alpha-Antagonists; Blood Pressure; Cardiovascular Agents; Circadian Rhythm; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Fractals; Heart Rate; Humans; Japan; Male; Middle Aged; Myocardial Ischemia; Propanolamines; Single-Blind Method	2004

Article

Year

Day-to-day variability of the long-term fractal component of heart rate variability (beta) and the effect of an antianginal agent in patients with silent myocardial ischemia.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2004, Volume: 58 Suppl 1

Topics: Adrenergic alpha-Antagonists; Blood Pressure; Cardiovascular Agents; Circadian Rhythm; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Fractals; Heart Rate; Humans; Japan; Male; Middle Aged; Myocardial Ischemia; Propanolamines; Single-Blind Method

2004

Other Studies

4 other study(ies) available for nipradilol and Heart Disease, Ischemic

Article	Year
Cardioprotection afforded by ischemic preconditioning interferes with chronic beta-blocker treatment. Scandinavian cardiovascular journal : SCJ, 2004, Volume: 38, Issue:5 Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Chronic Disease; Contraindications; Heart Ventricles; Ischemic Preconditioning; Lipid Peroxidation; Male; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide; Propanolamines; Propranolol; Random Allocation; Rats; Rats, Wistar; Safety	2004
Effect of nipradilol on silent myocardial ischemia, plasma beta-endorphin, and bradykinin in chronic stable angina. Clinical cardiology, 1996, Volume: 19, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; beta-Endorphin; Bradykinin; Chronic Disease; Electrocardiography, Ambulatory; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Propanolamines; Radioimmunoassay	1996
Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic cardiac function. The Annals of thoracic surgery, 1999, Volume: 68, Issue:3 Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arginine; Coronary Circulation; Enzyme Inhibitors; Heart; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Rabbits; Ventricular Pressure	1999
Effect of nipradilol on silent myocardial ischemia and heart rate variability in chronic stable angina. Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:1 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina Pectoris; Case-Control Studies; Electrocardiography; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Propanolamines	2002